Digestive Tract Cancer survival increased 3X if 2,000 IU of vitamin D and have high level of PD-L1 – RCT June 2021

Vitamin D Supplementation Regulates Postoperative Serum Levels of PD-L1 in Patients with Digestive Tract Cancer and Improves Survivals in the Highest Quintile of PD-L1: A Post Hoc Analysis of the AMATERASU Randomized Controlled Trial

Nutrients 2021, 13(6), 1987; https://doi.org/10.3390/nu13061987
by Makoto Morita 1,2,Mai Okuyama 1,Taisuke Akutsu 1,Hironori Ohdaira 3,Yutaka Suzuki 3 and Mitsuyoshi Urashima 1,*OrcID
1 Division of Molecular Epidemiology, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo 105-8461, Japan
2 Pfizer Japan Inc., Shinjuku Culture Quint Bldg, 3-22-7 Yoyogi, Shibuya-ku, Tokyo 151-8589, Japan
3 Department of Surgery, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara, Tochigi 329-2763, Japan

Because vitamin D responsive elements have been found to be located in the PD-L1 gene, vitamin D supplementation was hypothesized to regulate serum PD-L1 levels and thus alter survival time of cancer patients. A post hoc analysis of the AMATERASU randomized, double-blind, placebo-controlled trial of postoperative vitamin D3 supplementation (2000 IU/day) in 417 patients with stage I to stage III digestive tract cancer from the esophagus to the rectum was conducted. Postoperative serum PD-L1 levels were measured by ELISA and divided into quintiles (Q1–Q5). Serum samples were available for 396 (95.0%) of the original trial. Vitamin D supplementation significantly (p = 0.0008) up-regulated serum PD-L1 levels in the lowest quintile (Q1), whereas it significantly (p = 0.0001) down-regulated them in the highest quintile (Q5), and it did not either up- or down-regulate them in the middle quintiles (Q2–Q4).
Significant effects of vitamin D supplementation, compared with placebo on death (HR, 0.34; 95% CI, 0.12–0.92) and relapse/death (HR, 0.37; 95% CI, 0.15–0.89) were observed in the highest quintile (Q5) of serum PD-L1, whereas significant effects were not observed in other quintiles (Pinteraction = 0.02 for death, Pinteraction = 0.04 for relapse/death). Vitamin D supplementation significantly reduced the risk of relapse/death to approximately one-third in the highest quintile of serum PD-L1.
 Download the PDF from VitaminDWiki

---

Cancer - Colon category starts with the following

• Cancer - Colon category listing has 141 items

• see also:
  Overview Cancer-Colon and vitamin D.   Overview Cancer and vitamin D  Overview Gut and vitamin D   Cancer and Vitamin D - many studies
• Cancer - After diagnosis category listing has 110 items along with related searches
• 16 factors increase the risk of early-onset colorectal cancer, only vitamin D decreases the risk – meta-analysis May 2023
• Colorectal cancer 14 percent less likely if 10 ng more Vitamin D – 22nd meta-analysis – Sept 2022
• Colon cancer risk increases 30X if you have the worst vitamin D receptor mutation – Jan 2021

Items in both categories Vitamin D Receptor and Cancer - Colon:

• 2X more likely to survive a form of esophageal cancer in China if have good vitamin D receptor – Feb 2017

---

• Gastrointestinal Cancers - mostly positive Vitamin D studies – May 2019
• Gastric Cancer 8.8 times more likely if low vitamin D – Sept 2016
• Gastric Cancer patients with more vitamin D more likely to live– Feb 2012 has the following chart
• 

Other reports of the same study

• 2 X better survival of digestive cancer if 2,000 IU of Vitamin D plus good VDBP gene – RCT Feb 2020
• Digestive track Cancer (poorly differentiated) death 4X less likely if 2,000 IU of vitamin D – RCT Oct 2019
• Digestive tract cancer death rates reduced a bit by a bit of vitamin D – RCT April 2019